The introduction of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable buzz within the medical community. This groundbreaking dual GIP and GLP-1 agonist medication seems to provide significant improvements in weight shedding compared to existing therapies. Early patient studies have demonstrated marked declines in weight , possibly re